文献速递肺栓塞与肺血管病

右心房压呼吸变异对毛细血管前肺动脉高压的预后价值

Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients With Precapillary Pulmonary Hypertension.
PubMed 文献 · Chest · 2023-03-28

本研究回顾性分析毛细血管前肺动脉高压患者的右心房压波形,以呼吸变异≤2 mmHg定义为有效无变异。结果显示无变异组心脏指数更低、肺动脉血氧饱和度更低、肺血管阻力更高、右室功能障碍比例更高、BNP更高、1年内右心衰住院更多,1年死亡率有升高趋势。

要点

  • 右心房压呼吸变异≤2 mmHg提示右室对吸气前负荷增加耐受不良。
  • 无呼吸变异与右室功能障碍、不良血流动力学及更多右心衰住院相关。
  • 1年死亡率有升高趋势,需更大样本验证其预后分层价值。

核心结论

  • 右心房压缺乏呼吸变异与毛细血管前肺动脉高压患者的不良临床结局、不良血流动力学参数及右室功能障碍相关。

研究设计与样本

  • 回顾性研究,纳入接受右心导管检查的毛细血管前肺动脉高压患者,分析右心房压波形。
  • 以呼气末-吸气末右心房压差≤2 mmHg定义为有效无呼吸变异。

主要发现

  • 无呼吸变异组心脏指数(间接Fick法)更低:2.34 ± 0.09 vs 2.76 ± 0.1 L/min/m2,P = .001。
  • 无呼吸变异组肺动脉血氧饱和度更低:60% ± 1.02% vs 64% ± 1.15%,P = .007。
  • 无呼吸变异组肺血管阻力更高:8.9 ± 0.44 vs 6.1 ± 0.49 Wood units,P < .0001。
  • 无呼吸变异组超声右室功能障碍比例更高:87.3% vs 38.8%,P < .0001;BNP更高:2,163 ± 2,997 vs 633 ± 402 ng/mL,P < .0001。
  • 无呼吸变异组1年内右心衰住院更多:65.4% vs 29.6%,P < .0001;1年死亡率有升高趋势:25.4% vs 11.1%,P = .06。

关键数值与推荐

  • 右心房压呼吸变异(呼气末-吸气末)≤2 mmHg视为有效无有意义变异。

临床怎么用

  • 在右心导管检查中可关注右心房压呼吸变异,辅助识别右室功能障碍高风险患者。
  • 无呼吸变异者可能需要更密切随访和风险分层管理。

局限性

  • 回顾性研究设计。
  • 1年死亡率差异仅为趋势(P = .06),未达统计学显著。
  • 作者指出需要更大规模研究进一步评估其预后和风险分层效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Precapillary pulmonary hypertension is characterized by elevated mean pulmonary artery pressure from increased pulmonary vascular resistance. Lack of respiratory variation in right atrial pressure can be viewed as a surrogate for severe pulmonary hypertension and inability of the right ventricle to tolerate preload augmentation during inspiration. RESEARCH QUESTION: Is the lack of respiratory variation in right atrial pressure predictive of right ventricular dysfunction and worse clinical outcomes in precapillary pulmonary hypertension? STUDY DESIGN AND METHODS: We retrospectively reviewed right atrial pressure tracings of patients with precapillary pulmonary hypertension who underwent right heart catheterization. Patients with respiratory variation in right atrial pressure (end expiratory-end inspiratory) ≤ 2 mm Hg were considered to have effectively no meaningful variation in right atrial pressure. RESULTS: Lack of respiratory variation in right atrial pressure was associated with lower cardiac index by indirect Fick (2.34 ± 0.09 vs 2.76 ± 0.1 L/min/m2; P = .001), lower pulmonary artery saturation (60% ± 1.02% vs 64% ± 1.15%; P = .007), higher pulmonary vascular resistance (8.9 ± 0.44 vs 6.1 ± 0.49 Wood units, P < .0001), right ventricular dysfunction on echocardiography (87.3% vs 38.8%; P < .0001), higher pro brain natriuretic peptide (2,163 ± 2,997 vs 633 ± 402 ng/mL; P < .0001), and more hospitalizations within 1 year for right ventricular failure (65.4% vs 29.6%; P < .0001). There was also a trend toward higher mortality at 1 year in patients with no respiratory variation in right atrial pressure (25.4% vs 11.1%; P = .06). INTERPRETATION: Lack of respiratory variation in right atrial pressure is associated with poor clinical outcomes, adverse hemodynamic parameters, and right ventricular dysfunction in patients with precapillary pulmonary hypertension. Larger studies are needed to further evaluate its utility in prognosis and potential risk stratification in patients with precapillary pulmonary hypertension.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Al-Qadi MO, Holbrook J, Ford HJ, et al. Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients With Precapillary Pulmonary Hypertension. Chest. 2023. PMID: 36990147. doi:10.1016/j.chest.2023.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。